UvA-DARE (Digital Academic Repository) Epinephrine exerts anticoagulant effects during human endotoxemia
暂无分享,去创建一个
S. Lowry | S. Coyle | W. Buurman | P. Jansen | M. Levi | C. Braxton | C. Hack | J. Cate | M. Dentener | B. T. Poll
[1] T. van der Poll,et al. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. , 1996, The Journal of clinical investigation.
[2] F. Finkelman,et al. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2 , 1994, The Journal of experimental medicine.
[3] T. van der Poll,et al. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood , 1994, Infection and immunity.
[4] T. van der Poll,et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees , 1994, The Journal of experimental medicine.
[5] J. Kirkwood,et al. The pathogenesis of disseminated intravascular coagulation in sepsis. , 1994, JAMA.
[6] T. van der Poll,et al. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. , 1994, Blood.
[7] D. Abramowicz,et al. Interleukin‐10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide , 1993, European journal of immunology.
[8] T. V. Gopal,et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. , 1993, Journal of immunology.
[9] J. Neefjes,et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. , 1992, Immunology.
[10] C. Hunter,et al. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. , 1992, Journal of immunology.
[11] M. Cerqueira,et al. Fibrinolytic response during exercise and epinephrine infusion in the same subjects. , 1992, Journal of the American College of Cardiology.
[12] D. Crutchley,et al. The stable prostacyclin analog, iloprost, and prostaglandin E1 inhibit monocyte procoagulant activity in vitro. , 1991, Blood.
[13] C. Hack,et al. PAI-1 Synthesis in the Human Hepatoma Cell Line Hep G2 Is Increased by Cytokines - Evidence that the Liver Contributes to Acute Phase Behaviour of PAI-1 , 1991, Thrombosis and Haemostasis.
[14] J. D. Albert,et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. , 1987, Surgery, gynecology & obstetrics.
[15] A. Kjaeldgaard,et al. In vitro stimulation of plasminogen activator release from vein walls by adrenaline. , 1986, Journal of clinical pathology.
[16] K N Frayn,et al. HORMONAL CONTROL OF METABOLISM IN TRAUMA AND SEPSIS , 1986, Clinical endocrinology.
[17] D. Stern,et al. Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.
[18] I. Macdonald,et al. The effect of adrenaline upon cardiovascular and metabolic functions in man. , 1985, Clinical science.
[19] R. Snyderman,et al. Hormonal activation of adenylate cyclase in macrophage membranes is regulated by guanine nucleotides. , 1983, Journal of immunology.
[20] M. Boermeester,et al. Fat Emulsion Infusion Potentiates Coagulation Activation during Human Endotoxemia , 1996, Thrombosis and Haemostasis.
[21] T. van der Poll,et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. , 1994, The Journal of clinical investigation.
[22] W. Chandler,et al. A kinetic model of the circulatory regulation of tissue plasminogen activator during exercise, epinephrine infusion, and endurance training. , 1993, Blood.
[23] N. Mackman,et al. Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. , 1993, Blood.
[24] F. Taylor,et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. , 1991, Circulatory shock.